New approach to fighting obesity and diabetes
11 September, 2007Scientists at the University of Queensland (UQ) are using specially designed equipment to determine how to produce food which is better for us, but still tastes good.
Blood banking test automation
10 September, 2007BioTek Instruments has developed, in partnership with Immucor, an automated benchtop assay instrument for use in the blood transfusion industry. Manufactured by BioTek exclusively for Immucor, the Galileo Echo provides small to medium sized hospital blood bank laboratories with walk-away automation of tests such as ABO grouping and Rh (D) typing, detection/identification of IgG red blood cell antibodies, compatibility testing and red blood cell phenotyping for significant increases in productivity and patient safety while taking less time than other methods.
Australian cancer drugs get a shot in the arm
05 September, 2007Cancer Therapeutics (CTx) has commenced operations as one of the largest public/private partnerships of its type in the world.
Rabbit milk drug to combat HAE
27 August, 2007The clinical trial results of Rhucin, a drug for the treatment of Hereditary Angieoedema (HAE), will be presented at a press conference in London on 30 August.
Alzheimer's researcher receives high honour
16 August, 2007A neuroscientist was awarded the Victoria Prize, last night, for his groundbreaking research into Alzheimer's disease.
New research provides hope for childhood cancer sufferers
17 July, 2007Scientists investigating drug therapies for children with Acute Lymphoblastic Leukaemia (ALL) have presented new data demonstrating for the very first time that a small molecule called ABT-737 can increase the effectiveness of standard therapies.
Discovering dementia's molecular structure
06 July, 2007The Australian Synchrotron is due to open for general use later this year. The synchrotron will create beams of laser-like intense light that can be used for looking at materials in sub-microscopic detail and manufacturing small, precise materials
Cold sore suppression
26 June, 2007After the initial infection, the Herpes simplex 1 (HSV-1) virus usually remains in the body, hiding out in nearby nerve cells where the victim’s immune defenses cannot reach it, causing no symptoms at all.
Alzheimer’s biomarkers
21 June, 2007Scientists collaborating at Cornell University and Weill Cornell Medical College have identified a panel of 23 protein biomarkers in cerebrospinal fluid that acts as a neurochemical ‘fingerprint’, which doctors might use someday to identify patients living with Alzheimer’s disease.
Students devise an oral rotavirus vaccine
19 June, 2007A group of Johns Hopkins undergraduate biomedical engineering students have developed a rotavirus vaccine for infants that dissolves in the mouth like a popular breath freshener.
TB research wins Victorian medical award
05 June, 2007Melbourne epidemiologist Dr Helen Cox has won the 2007 Premier’s Award for Medical Research for her work on drug-resistant tuberculosis (TB).
Contract facility to speed medical research
30 May, 2007Australia's first preclinical contract R&D facility, TetraQ, was officially launched today to help speed the movement of medicines out of the laboratory and into the marketplace.
Staphylococcus aureus vaccine on track
29 May, 2007Austrian company Intercell has announced the completion of the phase I study of its Staphylococcus aureus vaccine.
Federal funding for a medical research powerhouse
09 May, 2007The federal government announced yesterday that it will back the development of a Brisbane-based major research centre, designed to test and produce new drugs for the medical industry.
Minority groups not genetically prone to diabetes
19 April, 2007A study by Australian and US researchers is helping dispel the 40-year-old ‘thrifty genotype theory’ – that certain minority groups are genetically prone to diabetes.
